Activation of intracellular signaling systems by high-density lipoproteins

被引:12
作者
Toth, Peter P. [1 ,2 ]
机构
[1] Sterling Rock Falls Clin, Sterling, IL 61081 USA
[2] Univ Illinois, Sch Med, Peoria, IL USA
关键词
High-density lipoproteins; G-protein coupled receptor; Nitric oxide; Protein kinase; Proteosome; Scavenger receptor BI; Sphingosine phosphate; NITRIC-OXIDE SYNTHASE; SPHINGOSINE; 1-PHOSPHATE; HDL; CHOLESTEROL; RECEPTOR; INHIBITION; STABILIZATION; PATHOGENESIS; MECHANISMS; EXPRESSION;
D O I
10.1016/j.jacl.2010.08.011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The proteosome of high-density lipoprotein particles is quite complex and consists of up to 75 different proteins and enzymes. The specific protein cargo of HDL particles regulates their functionality. In addition to their documented capacity to engage in reverse cholesterol transport, reduce oxidized lipid, and function as apoprotein donors, HDL particles can activate a variety of signaling systems in endothelial cells, smooth muscle cells, and platelets. The HDLs can deliver sphingolipids to the surface of these cell types and activate sphingosine phosphate receptors. Sphingosine phosphate receptors are coupled to numerous different intracellular signaling cascades exerting roles in vasodilatation, inflammation, cell migration and apoptosis, inhibition of platelet activation, and endothelial adhesion molecule expression, among other functions. The ability of HDL to influence such a diverse array of cellular functions lends biological plausibility to the substantial epidemiological and clinical evidence suggesting that the HDLs are unique among lipoproteins in that they are vasculoprotective and antiatherogenic. (C) 2010 National Lipid Association. All rights reserved.
引用
收藏
页码:376 / 381
页数:6
相关论文
共 37 条
[11]   High-density lipoproteins differentially modulate cytokine-induced expression of E-selectin and cyclooxygenase-2 [J].
Cockerill, GW ;
Saklatvala, J ;
Ridley, SH ;
Yarwood, H ;
Miller, NE ;
Oral, B ;
Nithyanathan, S ;
Taylor, G ;
Haskard, DO .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (04) :910-917
[12]   High-density lipoprotein and apolipoprotein Al increase endothelial NO synthase activity by protein association and multisite phosphorylation [J].
Drew, BG ;
Fidge, NH ;
Gallon-Beaumier, G ;
Kemp, BE ;
Kingwell, BA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (18) :6999-7004
[13]   High-density lipoprotein enhancement of anticoagulant activities of plasma protein S and activated protein C [J].
Griffin, JH ;
Kojima, K ;
Banka, CL ;
Curtiss, LK ;
Fernández, JA .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (02) :219-227
[14]   Erythrocytes store and release sphingosine 1-phosphate in blood [J].
Haenel, Petra ;
Andreani, Paul ;
Graeler, Markus H. .
FASEB JOURNAL, 2007, 21 (04) :1202-1209
[15]   The HDL proteome: a marker-and perhaps mediator-of coronary artery disease [J].
Heinecke, Jay W. .
JOURNAL OF LIPID RESEARCH, 2009, 50 :S167-S171
[16]   Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systems [J].
Krieger, M .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (06) :793-797
[17]   Charting the fate of the "good cholesterol": Identification and characterization of the high-density lipoprotein receptor SR-BI [J].
Krieger, M .
ANNUAL REVIEW OF BIOCHEMISTRY, 1999, 68 :523-558
[18]   Oxidative enzymopathies and vascular disease [J].
Leopold, JA ;
Loscalzo, J .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (07) :1332-1340
[19]   Current concepts of the pathogenesis of the acute coronary syndromes [J].
Libby, P .
CIRCULATION, 2001, 104 (03) :365-372
[20]   Mechanisms of plaque stabilization with statins [J].
Libby, P ;
Aikawa, M .
AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (4A) :4B-8B